Cabotegravir for preventing HIV-1 in adults and young people [ID6255]Status:In developmentProgramme:Technology appraisal guidanceExpected publication date: 11 September 2025
Lenacapavir for preventing HIV-1 in people aged 16 years or older [ID6495]Status:In developmentProgramme:Technology appraisal guidanceExpected publication date: 11 March 2026